DOCSLIB.ORG

Breast Cancer Control Policy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Breast Cancer Control Policy BREAST CANCER CONTROL POLICY BREAST CANCER CONTROL POLICY June 2017 1 BREAST CANCER CONTROL POLICY 2 BREAST CANCER CONTROL POLICY FOREWORD ..........................................................................................................................................4 ACKNOWLEDGEMENTS ......................................................................................................................5 ABBREVIATIONS AND ACRONYMS ...................................................................................................6 SECTION A: BACKGROUND AND THE SOUTH AFRICAN CONTEXT ..............................................7 CHAPTER 1: INTRODUCTION AND BACKGROUND .........................................................................7 CHAPTER 2: THE SOUTH AFRICAN CONTEXT .................................................................................8 2.1 EPIDEMIOLOGY ....................................................................................................................8 SECTION B: POLICY FRAMEWORK .................................................................................................10 CHAPTER 3: GENERAL POLICY DIRECTION ..................................................................................10 CHAPTER 4: POLICY GUIDING PRINCIPLES AND FRAMEWORK FOR CANCER PREVENTION AND CONTROL ..................................................................................11 SECTION C: STANDARDS OF CARE ................................................................................................13 Key Area 1: Prevention and early detection, screening and genetic assessment ................................14 Objective 1: Screening and early diagnosis .....................................................................................14 Objective 2: Risk assessment ..........................................................................................................15 Objective 3: Genetic services ...........................................................................................................17 Objective 4: Management of women known or suspected to have a breast cancer susceptibility gene mutation .......................................................................................19 Key Area 2: Timely access to care .......................................................................................................19 Objective 5: Specialist breast units for the diagnosis and management of breast disease ..............19 Objective 6: Clear referral pathways and access points to breast diagnosis ...................................21 Objective 7: Clear referral pathways and access points in breast cancer care ................................24 Key Area 3: Assessment, diagnosis and staging ..................................................................................25 Objective 8: Triple assessment .........................................................................................................25 Objective 9: Staging .........................................................................................................................28 Objective 10: Supportive care (including psychology) ......................................................................29 Objective 11: Patient navigation .......................................................................................................30 Key Area 4: Treatment of breast cancer ...............................................................................................31 Objective 12: Surgery (early and advanced breast cancer) .............................................................31 Objective 13: Breast reconstruction (immediate versus delayed) ....................................................34 Objective 14: Systemic therapy in early stage breast cancer ...........................................................35 Objective 15: Systemic therapy in locally- advanced stage breast cancer .......................................37 Objective 16: Systemic and local therapy in metastatic breast cancer .............................................38 Objective 17: Radiotherapy in breast cancer ....................................................................................40 Key Area 5: Palliative care in breast cancer .........................................................................................42 Objective 18: Palliative care management for patients ....................................................................42 Key Area 6: Follow-up and surveillance in breast cancer .....................................................................43 Objective 19: Appropriate cost-effective strategy for follow-up .........................................................43 Objective 20: Lymphedema care ......................................................................................................43 Key Area 7: Data, monitoring and research..........................................................................................44 Objective 21: Monitoring and research .............................................................................................44 Key Area 8: Community outreach and engagement .............................................................................44 Objective 22: Community engagement and CSOs ...........................................................................44 REFERENCES .....................................................................................................................................46 APPENDCES .......................................................................................................................................50 Appendix A: What is a breast unit? ...................................................................................................50 Appendix B: International breast cancer staging ..............................................................................52 Appendix C: Breast cancer patient protocol .....................................................................................53 Appendix D: Breast proforma ...........................................................................................................54 3 BREAST CANCER CONTROL POLICY FOREWORD The Breast Cancer Prevention and Control Policy is an important document aimed at prioritising breast cancer awareness, prevention, treatment and care in South Africa. It provides the clinical support for women, who are both at-risk of developing the disease later in life and are currently undergoing treatment, to survive and live healthy lives. Breast cancer, along with cervical cancer, has been identified as a national priority in South Africa. Breast cancer is the most prevalent cancer and a leading cause of death among South African women. The increasing incidence of breast cancer is a major health concern with 19.4 million women aged 15 years and older at-risk of contracting the disease. Per the National Cancer Registry in 2012, 8 203 new cases of breast were observed. Given the recent advances in medicine and technology, however, we have a tremendous opportunity to attack breast cancer energetically and effectively with a revised national programme. Against this background I am delighted to release the revised policy on breast cancer prevention and control. And it is being launched during an exciting period in the history of healthcare in South Africa –the introduction of the National Health Insurance. This updated policy entails the implementation of interdependent strategies: (i) increasing early recognition of breast cancer, (ii) treating breast cancer more effectively, and (iii) providing timely treatment and palliative care for invasive cancer. It also includes the administration of Trastuzumab for early stage cancer at designated sites nationally. We envisage that this policy, along with the accompanying programme implementation strategy and clinical guidelines, will be applied in the public sector at all levels of the health system thereby positively contributing to reducing breast cancer’s incidence and mortality rates as well as improving the quality of life for women in South Africa. Dr Aaron Motsoaledi Minister of Health 4 BREAST CANCER CONTROL POLICY ACKNOWLEDGEMENTS The national Department of Health would like to acknowledge the exceptional contribution of the writing group of breast cancer clinicians responsible for the KwaZulu-Natal breast cancer policy and Breast Interest Group of Southern Africa (BIGOSA). The majority of evidence for this policy is derived from their intellectual input and literature review. The authors of this document would like to make clear however, that any conclusions in this document and standards derived from this evidence are not necessarily the opinion of this writing group and should not be taken as such. The contributors consisted of breast surgeons, plastic and reconstructive surgeons, oncologists, radiologists, nuclear physicians, pathologists, geneticists and obstetrics and gynaecology specialists. In addition, experts in the various fields, including civil society organisations and other interest groups, were also contacted when necessary for further opinions. It is also worth noting that although considerable reference was made to the Malaysian guidelines because both countries are classified as middle-resource countries and demonstrate many similarities, this Breast Cancer Prevention and Control Policy document is aligned to the healthcare situation in South Africa
Load more

Recommended publications
  • Breast Reconstruction Surgery for Mastectomy in Hospital Inpatient and Ambulatory Settings, 2009–2014
    HEALTHCARE COST AND Agency for Healthcare UTILIZATION PROJECT Research and Quality STATISTICAL BRIEF #228 October 2017 Highlights Breast Reconstruction Surgery for ■ From 2009 to 2014, in 22 Mastectomy in Hospital Inpatient and States, the population rate of Ambulatory Settings, 2009–2014 breast reconstruction for mastectomy increased by 62 Adela M. Miller, B.S., Claudia A. Steiner, M.D., M.P.H., percent, from 21.7 to 35.1 per Marguerite L. Barrett, M.S., Kathryn R. Fingar, Ph.D., M.P.H., 100,000 women aged 18 years and Anne Elixhauser, Ph.D. or older. ■ Increases occurred for all age Introduction groups, but disproportionately so for women aged 65 years After a mastectomy (surgical removal of the breast), a woman and older, those covered by faces a complex and emotional decision about whether to have Medicare, and those who were breast reconstruction or live without a breast or breasts. There uninsured. are usually three main considerations in the decision: medical, sexual, and physical. Medical considerations include concerns ■ In 2014, women who lived in that breast reconstruction surgery lengthens recovery time and rural areas had fewer increases the chance for infection and other postoperative reconstructions (29 per 100 complications. Sexual considerations involve the impact of the mastectomies) compared with mastectomy on future sexual encounters. Physical features urban-dwelling women (41 include how breasts may define femininity and sense of self.1 reconstructions per 100 mastectomies). Several previous studies have shown an increase in breast ■ Growth in breast reconstructive 2,3,4 reconstruction for mastectomy. One study used a 2007 surgery was primarily national surgical database, another study used 2008 claims-based attributable to the following data of women insured through large private employers, and a factors: third study used the Nationwide Inpatient Sample (NIS) for 2005– 2011,5,6,7 part of the Healthcare Cost and Utilization Project o Ambulatory surgeries (HCUP) increased more than 150 percent.
    [Show full text]
  • Breast Reconstruction with Expanders and Implants
    Evidence-Based Clinical Practice Guideline: Breast Reconstruction with Expanders and Implants INTRODUCTION Disclaimer Evidence-based guidelines are strategies for patient management, The American Cancer Society estimates that nearly 230,000 American developed to assist physicians in clinical decision making. This women were diagnosed with invasive breast cancer in 2011.1 Many of guideline was developed through a comprehensive review of the these individuals will require mastectomy and total reconstruction of scientific literature and consideration of relevant clinical experience, the breast. The diagnosis and subsequent process can create signifi- and describes a range of generally acceptable approaches to diagnosis, cant confusion and distress for the affected persons and their families management, or prevention of specific diseases or conditions. This and, consequently, surgical treatment and reconstructive procedures guideline attempts to define principles of practice that should are of utmost importance in the breast cancer care continuum. In generally meet the needs of most patients in most circumstances. 2011, the American Society of Plastic Surgeons® (ASPS) reported an increase in the rate of breast reconstructions, citing nearly 100,000 However, this guideline should not be construed as a rule, nor procedures, of which the majority employed expanders/implants.2 should it be deemed inclusive of all proper methods of care The 3% increase in reconstructions over the course of just one year or exclusive of other methods of care reasonably directed at highlights the significance of maintaining patient safety and obtaining the appropriate results. It is anticipated that it will be optimizing surgical outcomes. necessary to approach some patients’ needs in different ways.
    [Show full text]
  • ASPS Clinical Practice Guideline Summary on Breast Reconstruction with Expanders and Implants
    CME ASPS Clinical Practice Guideline Summary on Breast Reconstruction with Expanders and Implants Amy Alderman, M.D., M.P.H. Learning Objectives: After reading this article, participants should be able to: Karol Gutowski, M.D. 1. Understand the evidence regarding the timing of expander/implant breast re- Amy Ahuja, M.P.H. construction in the setting of radiation therapy. 2. Discuss the implications of a Diedra Gray, M.P.H. patient’s risk factors for possible outcomes and complications of expander/implant Postmastectomy breast reconstruction. 3. Implement proper prophylactic antibiotic protocols. 4. Use Expander/Implant Breast the guidelines to improve their own clinical outcomes and reduce complications. Reconstruction Guideline Summary: In March of 2013, the Executive Committee of the American Society Work Group of Plastic Surgeons approved an evidence-based guideline on breast reconstruc- Arlington Heights, Ill. tion with expanders and implants, as developed by a guideline-specific work group commissioned by the society’s Health Policy Committee. The guideline addresses ten clinical questions: patient education, immediate versus delayed reconstruction, risk factors, radiation therapy, chemotherapy, hormonal therapy, antibiotic prophylaxis, acellular dermal matrix, monitoring for cancer recur- rence, and oncologic outcomes associated with implant-based reconstruction. The evidence indicates that patients undergoing mastectomy should be offered a preoperative referral to a plastic surgeon. Evidence varies regarding the as- sociation between postoperative complications and timing of postmastectomy expander/implant breast reconstruction. Evidence is limited regarding the opti- mal timing of expand/implant reconstruction in the setting of radiation therapy but suggests that irradiation to the expander or implant is associated with an increased risk of postoperative complications.
    [Show full text]
  • Silicone-Filled Breast Implants
    Important Information for Women About Breast Reconstruction with INAMED® Silicone-Filled Breast Implants RECON Patient Labeling Rev 11/03/06/06 page 1 TABLE OF CONTENTS Page GLOSSARY ..................................................................................................................................... 4 1. CONSIDERING SILICONE GEL-FILLED BREAST IMPLANT SURGERY ............................ 10 1.1 WHAT GIVES THE BREAST ITS SHAPE? ...................................................................... 11 1.2 WHAT IS A SILICONE GEL-FILLED BREAST IMPLANT? .............................................. 11 1.3 ARE SILICONE GEL-FILLED BREAST IMPLANTS RIGHT FOR YOU? ......................... 12 1.4 IMPORTANT FACTORS YOU SHOULD CONSIDER IN CHOOSING SILICONE GEL-FILLED BREAST IMPLANTS ................................................................. 12 2. BREAST IMPLANT COMPLICATIONS................................................................................... 14 2.1 WHAT ARE THE POTENTIAL COMPLICATIONS? ......................................................... 14 2.2 WHAT ARE OTHER REPORTED CONDITIONS? ........................................................... 19 3. ALLERGAN* CORE STUDY RESULTS .................................................................................. 22 3.1 OVERVIEW OF ALLERGAN’S CORE STUDY................................................................. 22 3.2 WHAT WERE THE 4-YEAR FOLLOW-UP RATES? ........................................................ 22 3.3 WHAT WERE THE BENEFITS? ......................................................................................
    [Show full text]
  • Your Options a Guide to Reconstruction for Breast Cancer
    Your Options A Guide to Reconstruction for Breast Cancer Options In this booklet Introduction to Breast Reconstruction ................................................................ 3 How to Make a Decision .............................................................................. 4 UMHS Team .......................................................................................... 6 Reconstruction Options Implants ........................................................................................... 7 Natural Tissue and Implants ....................................................................... 10 Lat Dorsi (Latissimus Dorsi) Flap Natural Tissue Reconstruction .................................................................... 11 Abdomen • Pedicled TRAM (Transverse Rectus Abdominis Myocutaneous) Flap • Free TRAM (Transverse Rectus Abdominis Myocutaneous) Flap • Free Muscle-Sparing TRAM (Transverse Rectus Abdominis Myocutaneous) Flap • Free DIEP (Deep Inferior Epigastric Perforator) Flap • Free SIEA (Superficial Inferior Epigastric Artery) Flap Alternative Donor Sites ........................................................................... 15 SGAP (Superior Gluteal Artery Perforator) Flap TUG (Transverse Upper Gracilis) Flap Additional Surgeries After Reconstruction ........................................................ 17 • Nipple Reconstruction • Breast Lift, Augmentation, Reduction Terms to Know .................................................................................... 19 “I’m a wife and mother and I
    [Show full text]
  • Breast Augmentation Surgery: Clinical Considerations
    REVIEW DEMETRIUS M. COOMBS, MD RITWIK GROVER, MD ALEXANDRE PRASSINOS, MD RAFFI GURUNLUOGLU, MD, PhD Department of Plastic Surgery, Department of Plastic Surgery, Division of Plastic and Reconstructive Department of Plastic Surgery, Dermatology and Dermatology and Plastic Surgery Institute, Dermatology and Plastic Surgery Surgery, Department of Surgey, Plastic Surgery Institute, Cleveland Clinic; Profes- Cleveland Clinic Institute, Cleveland Clinic Yale School of Medicine, New Haven, CT sor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH Breast augmentation surgery: Clinical considerations ABSTRACT t present, 300,000 US women undergo Abreast augmentation surgery each year,1 Women receive breast implants for both aesthetic and making this the second most common aes- reconstructive reasons. This brief review discusses the thetic procedure in women (after liposuc- evolution of and complications related to breast implants, tion),2–4 and making it extremely likely that as well as key considerations with regard to aesthetic clinicians will encounter women who have and reconstructive surgery of the breast. breast implants. In addition, approximately 110,000 women undergo breast reconstruc- KEY POINTS tive surgery after mastectomy, of whom more Nearly 300,000 breast augmentation surgeries are per- than 88,000 (81%) receive implants (2016 5 formed annually, making this the second most common data). aesthetic procedure in US women (after liposuction). This review discusses the evolution of breast implants, their complications, and key considerations with regard to aesthetic and Today, silicone gel implants dominate the world market, reconstructive breast surgery, as the principles and in the United States, approximately 60% of implants are similar. contain silicone gel fi ller.
    [Show full text]
  • The Decision Guide to Breast Reconstruction
    THE DECISION GUIDE TO BREAST RECONSTRUCTION Breast reconstruction is the process of making a new breast after mastectomy (removal of the breast) for breast cancer treatment or prevention (“therapeutic” or “prophylactic” mastectomies). This web site contains information to assist you in making choices related to breast reconstruction following mastectomy. Our goal is to give you understandable, up-to-date facts about reconstructive options. We hope this site answers many of your questions, lets you know what to expect, and helps you make a decision that you feel good about. How to Use This Program This guide can be used in a variety of ways. If you are planning to consult your health care provider about breast reconstruction, we recommend that you spend some time reviewing this information before your provider visit. The basic knowledge included in this guide will help you partner with your surgeon to choose reconstruction options which are right for you. Following your consultation, the web site may assist in clarifying issues raised during your visit. Remember — you and your surgeon are a team, working together to make treatment decisions which fit your values, priorities and lifestyle. The Reconstruction Decision When you lose a breast to cancer, it is comforting to think you can replace it and look and feel almost normal again. However, treating the cancer and getting back to a healthy life should always be your first concerns. If you are able to have breast reconstruction, make your decision about whether to have reconstruction, when to have reconstruction, and what kind of reconstruction to have based on what is best for you.
    [Show full text]
  • Breast Reconstruction Or Prosthesis After Mastectomy
    BREAST RECONSTRUCTION OR PROSTHESIS AFTER MASTECTOMY Breast reconstruction Breast reconstruction can help restore the look of the breast after a mastectomy. It can be done at the same time as the mastectomy (immediate) or later (delayed). The timing depends on: • A physical exam by the plastic surgeon • Surgical risk factors (such as smoking and being overweight) – Women who smoke or are overweight have a higher risk of problems with surgery. Sometimes, waiting to have reconstruction until after you quit smoking or lose weight may lower these risks • Treatments you will need after surgery Types of breast reconstruction Breast implant Breast reconstruction can be done with: associated anaplastic large cell lymphoma • Breast implants (BIA-ALCL) • Tissue flaps (using skin, fat and sometimes, muscle from your body) BIA-ALCL is a rare • A combination of both cancer of the cells of There’s no one best reconstruction method. There are pros and cons to each. Breast the immune system in women with breast implants require less invasive surgery than using your own body tissues, but the results may implants. not look and feel as natural. • The FDA is studying Your breast cancer treatment, your body and your lifestyle will affect your options. Talk the link between with your doctors about what type of reconstruction is right for you. breast implants and a slight increase in risk Breast Implants of BIA-ALCL. There are 2 basic types of breast implants: • The risk of BIA-ALCL saline and silicone. Implants come in appears to be linked to textured breast different shapes to match the look of the implants rather than natural breast.
    [Show full text]
  • Imaging After Mastectomy and Breast Reconstruction
    New 2020 American College of Radiology ACR Appropriateness Criteria® Imaging after Mastectomy and Breast Reconstruction Variant 1: Female. Breast cancer screening. History of cancer, mastectomy side(s), no reconstruction. Procedure Appropriateness Category Relative Radiation Level US breast Usually Not Appropriate O Digital breast tomosynthesis screening Usually Not Appropriate ☢☢ Mammography screening Usually Not Appropriate ☢☢ MRI breast without and with IV contrast Usually Not Appropriate O MRI breast without IV contrast Usually Not Appropriate O Sestamibi MBI Usually Not Appropriate ☢☢☢ FDG-PET breast dedicated Usually Not Appropriate ☢☢☢☢ Variant 2: Female. Breast cancer screening. History of cancer, autologous reconstruction side(s) with or without implant. Procedure Appropriateness Category Relative Radiation Level Digital breast tomosynthesis screening May Be Appropriate ☢☢ Mammography screening May Be Appropriate ☢☢ US breast Usually Not Appropriate O MRI breast without and with IV contrast Usually Not Appropriate O MRI breast without IV contrast Usually Not Appropriate O Sestamibi MBI Usually Not Appropriate ☢☢☢ FDG-PET breast dedicated Usually Not Appropriate ☢☢☢☢ Variant 3: Female. Breast cancer screening. History of cancer, nonautologous (implant) reconstruction side(s). Procedure Appropriateness Category Relative Radiation Level US breast Usually Not Appropriate O Digital breast tomosynthesis screening Usually Not Appropriate ☢☢ Mammography screening Usually Not Appropriate ☢☢ MRI breast without and with IV contrast Usually
    [Show full text]
  • Breast Reconstruction Surgery
    Breast Reconstruction Surgery I. Policy University Health Alliance (UHA) will reimburse for Breast Reconstruction Surgery when it is determined to be medically necessary and when it meets the medical criteria guidelines (subject to limitations and exclusions) indicated below. II. Criteria/Guidelines A. UHA considers reconstructive breast surgery medically necessary after a medically necessary mastectomy or partial mastectomy that results in a significant deformity amenable to surgical correction. a. This benefit does not include aspirations, biopsy (open or core), excision of cysts, aberrant breast tissue, duct lesions, nipple or areolar lesions, or treatment of gynecomastia. b. There is not a time frame in which the enrollee is required to have the reconstruction done post mastectomy under the Women's Health and Cancer Rights Act of 1998. B. Medically necessary procedures include (when applicable): a. The use of tissue expanders, insertion of breast prostheses, contralateral mastopexy, or autologous tissue reconstruction. b. Autologous fat grafting as a replacement for implants for breast reconstruction or to fill defects after breast conservation surgery or other reconstructive techniques, is covered only when appropriate. C. UHA considers associated nipple and areola reconstruction and tattooing of the nipple area medically necessary. D. In accordance with Federal mandates the following are covered: a. All stages of reconstruction of the breast on which the mastectomy was performed b. Surgery and reconstruction of the contralateral breast to produce a symmetrical appearance, including nipple tattooing c. Prostheses (implanted or external) d. Treatment of physical complications of mastectomy, including lymphedema and infection i. Complex Decongestive Physiotherapy (CDP) is covered for the confirmed complication of lymphedema post-mastectomy.
    [Show full text]
  • Breast-Augmentation-Techniques.Pdf
    CME Breast Augmentation David A. Hidalgo, M.D. Learning Objectives: After studying this article , the participant should be able to: Jason A. Spector, M.D. 1. Assess patient physical characteristics that influence implant selection. 2. Adopt New York, N.Y. a system to aid in implant size selection. 3. Become cognizant of the advantages and disadvantages of incision, pocket plane, and implant options. 4. Understand implant positioning concepts and aseptic implant handling methods. 5. Manage untoward postoperative sequelae 6. Understand secondary surgery concepts. Summary: Breast augmentation is the most commonly performed aesthetic surgi- cal procedure. Choices of incisions, pocket plane, and myriad implant character- istics constitute the basis for surgical planning. Analysis of physical characteristics and inclusion of the patient in implant selection contribute to overall satisfac- tion and reduce requests for secondary surgery. Technical expertise in implant positioning and aseptic handling helps to prevent capsular contracture, implant malposition, and other shape problems. Despite the need for secondary surgery in some, patient satisfaction is high. (Plast. Reconstr. Surg. 133: 567e, 2014.) reast augmentation is the most common aes- personality and aesthetics. Anatomic limitations thetic surgical procedure, with more than must be explained to the patient. B300,000 performed in 2011.1 Choices of Height and weight influence implant selec- incisions, pocket plane, and implant characteris- tion. For example, tall patients require larger tics, including shape, texture, filler, and volume, volumes than short patients to achieve a similarly constitute the key decisions in surgical planning. proportioned result. Thin patients are not well Thoughtful analysis of physical characteristics and suited to saline implants.
    [Show full text]
  • Image Quality of Digital Breast Tomosynthesis: Optimization in Image Acquisition and Reconstruction
    Image Quality of Digital Breast Tomosynthesis: Optimization in Image Acquisition and Reconstruction by Gang Wu A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Graduate Department of Medical Biophysics University of Toronto c Copyright 2014 by Gang Wu Abstract Image Quality of Digital Breast Tomosynthesis: Optimization in Image Acquisition and Reconstruction Gang Wu Doctor of Philosophy Graduate Department of Medical Biophysics University of Toronto 2014 Breast cancer continues to be the most frequently diagnosed cancer in Canadian women. Currently, mammography is the clinically accepted best modality for breast cancer detection and the regular use of screening has been shown to contribute to reduced mortality. However, mammography suffers from several drawbacks which limit its sensitivity and specificity. As a potential solution, digital breast to- mosynthesis (DBT) uses a limited number (typically 10{20) of low-dose x-ray projections to produce a three-dimensional tomographic representation of the breast. The reconstruction of DBT images is challenged by such incomplete sampling. The purpose of this thesis is to evaluate the effect of image acquisition parameters on image quality of DBT for various reconstruction techniques and to optimize these, with three specific goals: A) Develop a better power spectrum estimator for detectability calcu- lation as a task-based image quality index; B) Develop a paired-view algorithm for artifact removal in DBT reconstruction; and C) Increase dose efficiency in DBT by reducing random noise. A better power spectrum estimator was developed using a multitaper technique, which yields reduced bias and variance in estimation compared to the conventional moving average method.
    [Show full text]